TMCnet News
William Young Joins Vertex Board of Directors [Global Data Point](Global Data Point Via Acquire Media NewsEdge) "Mr. Young is a recognized leader within the biotech industry and brings a wealth of scientific and operational experience to our Board," said Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex. "Importantly, Mr. Young has been part of multiple life sciences companies at times of rapid growth and transition. His insights will be invaluable to Vertex as we continue to focus our business on advancing transformative medicines for people with cystic fibrosis." Mr. Young has extensive experience in leadership roles within major life sciences and pharmaceutical companies. He spent nearly two decades at Genentech Inc., serving as its Chief Operating Officer from 1997 to 1999, and more recently was Chairman and Chief Executive Officer of Monogram Biosciences, Inc., a provider of molecular diagnostics, from 1999 to 2009. During his time at Genentech, the company launched a number of new medicines for diseases ranging from cystic fibrosis to breast cancer. Mr. Young is the retiring Chairman of the Board of Directors of Biogen Idec, a position he has held since 2010. He has also been the Chairman of NanoString Technologies since 2010 and is a Director for Biomarin Pharmaceutical Inc. and Theravance, Inc. Mr. Young is a venture partner at Clarus Ventures, LLC, a life sciences venture capital firm that he joined in 2010. Mr. Young earned a Bachelor's of Science in Chemical Engineering from Purdue University, an M.B.A. from Indiana University and an Honorary Doctorate in Engineering from Purdue University. In 1993, Mr. Young was elected to the National Academy of Engineering for his contributions to biotechnology. (c) 2014 GlobalData Provided by Syndigate.info, an Albawaba.com company [ Back To TMCnet.com's Homepage ] |